benefix intravenous 1000 (ベネフィクス静注用1000)
pfizer pharmaceuticals inc. - nonacog alfa (genetical recombination) - white freeze-dry powder injection
benefix intravenous 2000 (ベネフィクス静注用2000)
pfizer pharmaceuticals inc. - nonacog alfa (genetical recombination) - white freeze-dry powder injection
benefix intravenous 3000 (ベネフィクス静注用3000)
pfizer pharmaceuticals inc. - nonacog alfa (genetical recombination) - white freeze-dry powder injection
benefix intravenous 500 (ベネフィクス静注用500)
pfizer pharmaceuticals inc. - nonacog alfa (genetical recombination) - white freeze-dry powder injection
alprolix
pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 1000 [iu]; - powder for infusion - 1000 iu - active: eftrenonacog alfa 1000 [iu] excipient: histidine mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)
alprolix
pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 250 [iu]; - powder for infusion - 250 iu - active: eftrenonacog alfa 250 [iu] excipient: histidine mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)
alprolix
pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 3000 [iu]; - powder for infusion - 3000 iu - active: eftrenonacog alfa 3000 [iu] excipient: histidine mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)
alprolix
pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 500 [iu]; - powder for infusion - 500 iu - active: eftrenonacog alfa 500 [iu] excipient: histidine mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)
alprolix
pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 4000 [iu]; - powder for infusion - 4000 iu - active: eftrenonacog alfa 4000 [iu] excipient: histidine hydrochloric acid mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)
benefix 250 ui 1 vial + jer disolv 5 ml